Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
Cash to Debt 184.17
DYII's Cash to Debt is ranked higher than
93% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. DYII: 184.17 )
DYII' s 10-Year Cash to Debt Range
Min: 0.25   Max: No Debt
Current: 184.17

Equity to Asset 0.64
DYII's Equity to Asset is ranked higher than
88% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. DYII: 0.64 )
DYII' s 10-Year Equity to Asset Range
Min: 0.54   Max: 0.89
Current: 0.64

0.54
0.89
F-Score: 7
Z-Score: 0.49
M-Score: -2.15
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
Operating margin (%) -42.95
DYII's Operating margin (%) is ranked lower than
52% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 8.52 vs. DYII: -42.95 )
DYII' s 10-Year Operating margin (%) Range
Min: -491.12   Max: 992.41
Current: -42.95

-491.12
992.41
Net-margin (%) -33.82
DYII's Net-margin (%) is ranked lower than
52% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 4.94 vs. DYII: -33.82 )
DYII' s 10-Year Net-margin (%) Range
Min: -219.69   Max: 1063.02
Current: -33.82

-219.69
1063.02
ROE (%) -9.99
DYII's ROE (%) is ranked higher than
56% of the 292 Companies
in the Global Medical Care industry.

( Industry Median: 9.59 vs. DYII: -9.99 )
DYII' s 10-Year ROE (%) Range
Min: -40.22   Max: 51.09
Current: -9.99

-40.22
51.09
ROA (%) -6.67
DYII's ROA (%) is ranked higher than
53% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 3.53 vs. DYII: -6.67 )
DYII' s 10-Year ROA (%) Range
Min: -29.81   Max: 32.19
Current: -6.67

-29.81
32.19
ROC (Joel Greenblatt) (%) -59.92
DYII's ROC (Joel Greenblatt) (%) is ranked higher than
50% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 17.51 vs. DYII: -59.92 )
DYII' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -170.19   Max: 127.6
Current: -59.92

-170.19
127.6
Revenue Growth (3Y)(%) -20.60
DYII's Revenue Growth (3Y)(%) is ranked higher than
51% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. DYII: -20.60 )
DYII' s 10-Year Revenue Growth (3Y)(%) Range
Min: -61.2   Max: 66.3
Current: -20.6

-61.2
66.3
EBITDA Growth (3Y)(%) -28.20
DYII's EBITDA Growth (3Y)(%) is ranked higher than
53% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. DYII: -28.20 )
DYII' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 136.6
Current: -28.2

0
136.6
EPS Growth (3Y)(%) -11.00
DYII's EPS Growth (3Y)(%) is ranked higher than
63% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 13.80 vs. DYII: -11.00 )
DYII' s 10-Year EPS Growth (3Y)(%) Range
Min: -11   Max: 93.9
Current: -11

-11
93.9
» DYII's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

DYII Guru Trades in

Q2 2012

DYII Guru Trades in Q2 2012

Jim Simons 21,700 sh (unchged)
» More
Q3 2012

DYII Guru Trades in Q3 2012

Jim Simons 21,900 sh (+0.92%)
» More
Q4 2012

DYII Guru Trades in Q4 2012

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with DYII

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.18
DYII's P/B is ranked higher than
100% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. DYII: 0.18 )
DYII' s 10-Year P/B Range
Min: 0.01   Max: 2.26
Current: 0.18

0.01
2.26
P/S 0.63
DYII's P/S is ranked higher than
87% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.60 vs. DYII: 0.63 )
DYII' s 10-Year P/S Range
Min: 0.01   Max: 36.27
Current: 0.63

0.01
36.27
PFCF 4.75
DYII's PFCF is ranked higher than
98% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 44.91 vs. DYII: 4.75 )
DYII' s 10-Year PFCF Range
Min: 0.13   Max: 87.5
Current: 4.75

0.13
87.5
EV-to-EBIT 3.08
DYII's EV-to-EBIT is ranked higher than
99% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 23.74 vs. DYII: 3.08 )
DYII' s 10-Year EV-to-EBIT Range
Min: -48.1   Max: 350.8
Current: 3.08

-48.1
350.8
Current Ratio 1.14
DYII's Current Ratio is ranked higher than
68% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. DYII: 1.14 )
DYII' s 10-Year Current Ratio Range
Min: 1.02   Max: 12.77
Current: 1.14

1.02
12.77
Quick Ratio 1.12
DYII's Quick Ratio is ranked higher than
70% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. DYII: 1.12 )
DYII' s 10-Year Quick Ratio Range
Min: 0.9   Max: 12.56
Current: 1.12

0.9
12.56

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 3.80
DYII's Price/Net Current Asset Value is ranked higher than
99% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. DYII: 3.80 )
DYII' s 10-Year Price/Net Current Asset Value Range
Min: 0.18   Max: 1579.9
Current: 3.8

0.18
1579.9
Price/Tangible Book 0.13
DYII's Price/Tangible Book is ranked higher than
100% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 15.21 vs. DYII: 0.13 )
DYII' s 10-Year Price/Tangible Book Range
Min: 0.01   Max: 10.7
Current: 0.13

0.01
10.7
Price/DCF (Projected) 0.51
DYII's Price/DCF (Projected) is ranked higher than
98% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 3.63 vs. DYII: 0.51 )
DYII' s 10-Year Price/DCF (Projected) Range
Min: 0.01   Max: 8.32
Current: 0.51

0.01
8.32
Price/Median PS Value 0.38
DYII's Price/Median PS Value is ranked higher than
98% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. DYII: 0.38 )
DYII' s 10-Year Price/Median PS Value Range
Min: 0.03   Max: 20.12
Current: 0.38

0.03
20.12
Earnings Yield (Greenblatt) 32.50
DYII's Earnings Yield (Greenblatt) is ranked higher than
99% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 4.60 vs. DYII: 32.50 )
DYII' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.3   Max: 8374.5
Current: 32.5

0.3
8374.5
Forward Rate of Return (Yacktman) 92.04
DYII's Forward Rate of Return (Yacktman) is ranked higher than
100% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 13.11 vs. DYII: 92.04 )
DYII' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5237.1   Max: 14000
Current: 92.04

-5237.1
14000

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Dynacq Healthcare, Inc. was incorporated in Nevada in February 1992. The Company was reincorporated in Delaware in November 2003 and reincorporated back in Nevada in August 2007. The Company is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its United States subsidiaries owns and operates one general acute care hospital in Pasadena, Texas. The Company through its subsidiary in Hong Kong invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings. The Company's hospital, Surgery Specialty Hospitals of America - Southeast Houston Campus in Pasadena, Texas, near Houston (the Pasadena facility), includes operating rooms, pre- and post-operative space, intensive care units, nursing units and diagnostic facilities, as well as adjacent medical office buildings. The Company operates in the greater Houston, Texas market. In the United States, the Company manages and operates one general acute care hospital that principally provides specialized surgeries such as bariatric, orthopedic and neuro-spine surgeries. The Company competes with other providers, including major acute care hospitals. It also encounters competition with other companies for strategic relationships with physicians. The Company complies with government regulation at the federal, state and local levels.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK